Clinical Trial Update: Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy trial comparing ABT-143 to simvastatin in individuals with dyslipidemia, hypercholesterolemia, and hypertriglyceridemia; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• ABT-143
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2012-08-01